- Home
- BBIO vs IPG Comparison
BBIO vs IPG Comparison
Compare BBIO & IPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- IPG
- Stock Information
- Founded
- BBIO 2015
- IPG 1902
- Country
- BBIO United States
- IPG United States
- Employees
- BBIO N/A
- IPG N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- IPG Advertising
- Sector
- BBIO Health Care
- IPG Consumer Discretionary
- Exchange
- BBIO Nasdaq
- IPG Nasdaq
- Market Cap
- BBIO 9.4B
- IPG 9.9B
- IPO Year
- BBIO 2019
- IPG N/A
- Fundamental
- Price
- BBIO $53.33
- IPG $26.01
- Analyst Decision
- BBIO Strong Buy
- IPG Buy
- Analyst Count
- BBIO 16
- IPG 6
- Target Price
- BBIO $64.44
- IPG $31.02
- AVG Volume (30 Days)
- BBIO 2.1M
- IPG 4.9M
- Earning Date
- BBIO 11-11-2025
- IPG 10-21-2025
- Dividend Yield
- BBIO N/A
- IPG 5.06%
- EPS Growth
- BBIO N/A
- IPG N/A
- EPS
- BBIO N/A
- IPG 1.18
- Revenue
- BBIO $235,812,000.00
- IPG $8,846,600,000.00
- Revenue This Year
- BBIO $115.97
- IPG N/A
- Revenue Next Year
- BBIO $65.50
- IPG $2.77
- P/E Ratio
- BBIO N/A
- IPG $22.04
- Revenue Growth
- BBIO 7.62
- IPG N/A
- 52 Week Low
- BBIO $21.72
- IPG $22.51
- 52 Week High
- BBIO $54.60
- IPG $33.05
- Technical
- Relative Strength Index (RSI)
- BBIO 60.01
- IPG 46.75
- Support Level
- BBIO $49.94
- IPG $25.99
- Resistance Level
- BBIO $54.29
- IPG $26.86
- Average True Range (ATR)
- BBIO 2.06
- IPG 0.56
- MACD
- BBIO -0.18
- IPG -0.13
- Stochastic Oscillator
- BBIO 73.81
- IPG 15.06
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About IPG Interpublic Group of Companies Inc. (The)
Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services, such as public relations, through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe.